Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3098]

ELCC 2016: Patients with EGFR expressing non-small-cell lung cancer benefit most from necitumumab added to chemotherapy

ELCC 2016: Patients with EGFR expressing non-small-cell lung cancer benefit most from necitumumab added to...

ELCC 2016: Studies confirm benefit of plasma genotyping to predict treatment benefit in patients with non-small-cell lung cancer

ELCC 2016: Studies confirm benefit of plasma genotyping to predict treatment benefit in patients with non-small...

Treatment for chronic hepatitis B linked to increased rates of colorectal and cervical cancer

Treatment for chronic hepatitis B linked to increased rates of colorectal and cervical cancer

Genomic makeup of colorectal cancers predicts immune system ability to fight tumours

Genomic makeup of colorectal cancers predicts immune system ability to fight tumours

Combined neratinib plus paclitaxel versus trastuzumab plus paclitaxel in breast cancer

Combined neratinib plus paclitaxel versus trastuzumab plus paclitaxel in breast cancer

Incidence of diagnosed thyroid cancer may be leveling off

Incidence of diagnosed thyroid cancer may be leveling off

Osimertinib given as first-line treatment may alter biology of EGFR mutated non-small-cell lung cancer

Osimertinib given as first-line treatment may alter biology of EGFR mutated non-small-cell lung cancer

Identification of a pro-metastatic protein

Identification of a pro-metastatic protein

Repairing DNA damage in the human body

Repairing DNA damage in the human body

European approval for nivolumab against lung and kidney cancers

European approval for nivolumab against lung and kidney cancers

More from ecancer